• Immunic appointed Jaa Roberson chief people officer, effective October 19, 2026.
• Roberson will report to CEO Erik Lundgren and join the executive leadership team.
• Previously chief people officer at Day One Biopharmaceuticals, she brings more than two decades of human resources experience.
• She will lead global talent and organizational strategy to support the potential commercialization of vidofludimus calcium for multiple sclerosis.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunic Inc. published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2417410_en) on October 19, 2026, and is solely responsible for the information contained therein.